Stay updated with breaking news from Chest Physicians. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
COVID-19 severity upon hospital admission is associated with interstitial lung disease (ILD) at 3 months following discharge in patients without cancer.
In patients with COPD, delaying triple therapy initiation until after a second moderate event may increase future exacerbations.
Triple therapy is linked to decreased risk of moderate/severe exacerbations in patients with COPD and an eosinophil count of 300 cells/µL or more.
No new safety signals and steroid use appeared to be reduced, but questions remain.
Acute exacerbations of COPD appear to be significantly less likely in those who use cannabis.